Pfizer | PFE - Capital De Empréstimo

Preço das Ações
27.47
Mudança Diária
0.37 1.37%
Mensal
2.46%
Anual
22.14%
Q2 Previsão
27.47




Capital De Empréstimo Alterar Data
AbbVie USD 62.97B 12M 2025-09
Abbott USD 9.9B 1.7B 2025-12
ALKERMES USD 285.82M 639K 2024-09
Amgen USD 50B 2.43B 2025-12
AstraZeneca USD 26.14B 19.58B 2025-12
Bayer EUR 31.83B 877M 2025-12
Biogen USD 6.29B 1.4M 2025-09
Bristol-Myers Squibb USD 42.85B 1.62B 2025-12
Coherus Biosciences USD 51.08M 496K 2025-12
Drreddys Laboratories INR 129.19M 1.84M 2025-12
Eli Lilly USD 40.87B 5.6M 2025-12
Gilead Sciences USD 22.14B 5M 2025-09
GlaxoSmithKline GBP 14.71B 186M 2025-12
Glaxosmithkline GBP 19.82B 203.13M 2025-12
J&J USD 39.44B 30M 2025-12
Medtronic USD 27.88B 255M 2025-12
Merck USD 39.97B 6B 2025-09
Neurocrine Biosciences USD 169.5M 500K 2023-03
Novartis USD 29.59B 5.35B 2025-12
Novartis USD 29.59B 5.35B 2025-12
Pacira USD 372.19M 4.53M 2025-12
Perrigo USD 3.6B 4.5M 2025-12
Pfizer USD 57.41B 93M 2025-09
Phibro Animal Health USD 603.6M 5.92M 2025-12
Prestige Brands USD 1.05B 39.73M 2025-12
Regeneron Pharmaceuticals USD 2.71B 720.4M 2025-12
Roche Holding CHF 27.43B 966M 2025-12
Sanofi EUR 15.72B 2.45B 2025-12
Sanofi EUR 15.72B 150.06M 2025-12
Vertex Pharmaceuticals USD 111.4M 1.4M 2025-03
Zoetis USD 9.04B 1.97B 2025-12